Elizabeth Branson, | |
2010 E 1st St # 100, Santa Ana, CA 92705-4079 | |
(909) 800-3532 | |
Not Available |
Full Name | Elizabeth Branson |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 6 Years |
Location | 2010 E 1st St # 100, Santa Ana, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023587516 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LA2100X | Nurse Practitioner - Acute Care | 95010148 (California) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Scientia Caritas Medicine | 6608271119 | 2 |
News Archive
Those have undergone extensive back surgery and need repeated X-rays to monitor their progress may soon have access to a new technology that skips the X-rays and repeated radiation exposure, opting instead for an innovative, noninvasive, non-X-ray device that evaluates spinal movement.
Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, announced today a national agreement with Aetna, one of the nation's leading diversified health care benefits companies that serves approximately 36.3 million people. Under the terms of the three-year ancillary services agreement which went into effect February 1, 2010, Millennium Laboratories' will assist Aetna participating physicians nationwide with state-of-the-art therapeutic drug monitoring services and tools.
The U.S. Food and Drug Administration (FDA) has approved raltegravir tablets for treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.
The U.N. World Food Programme (WFP) on Tuesday posted an infographic that answers such questions as "how many people does WFP feed each year?" and "how much does that cost and where does it get the money?"
UCLA AIDS Institute researchers successfully removed CCR5 - a cell receptor to which HIV-1 binds for infection but which the human body does not need - from human cells. Individuals who naturally lack the CCR5 receptor have been found to be essentially resistant to HIV.
› Verified 7 days ago
Entity Name | Elite Pain Management Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346449394 PECOS PAC ID: 6204922388 Enrollment ID: O20081204000636 |
News Archive
Those have undergone extensive back surgery and need repeated X-rays to monitor their progress may soon have access to a new technology that skips the X-rays and repeated radiation exposure, opting instead for an innovative, noninvasive, non-X-ray device that evaluates spinal movement.
Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, announced today a national agreement with Aetna, one of the nation's leading diversified health care benefits companies that serves approximately 36.3 million people. Under the terms of the three-year ancillary services agreement which went into effect February 1, 2010, Millennium Laboratories' will assist Aetna participating physicians nationwide with state-of-the-art therapeutic drug monitoring services and tools.
The U.S. Food and Drug Administration (FDA) has approved raltegravir tablets for treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.
The U.N. World Food Programme (WFP) on Tuesday posted an infographic that answers such questions as "how many people does WFP feed each year?" and "how much does that cost and where does it get the money?"
UCLA AIDS Institute researchers successfully removed CCR5 - a cell receptor to which HIV-1 binds for infection but which the human body does not need - from human cells. Individuals who naturally lack the CCR5 receptor have been found to be essentially resistant to HIV.
› Verified 7 days ago
Entity Name | Scientia Caritas Medicine |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588231187 PECOS PAC ID: 6608271119 Enrollment ID: O20210823000226 |
News Archive
Those have undergone extensive back surgery and need repeated X-rays to monitor their progress may soon have access to a new technology that skips the X-rays and repeated radiation exposure, opting instead for an innovative, noninvasive, non-X-ray device that evaluates spinal movement.
Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, announced today a national agreement with Aetna, one of the nation's leading diversified health care benefits companies that serves approximately 36.3 million people. Under the terms of the three-year ancillary services agreement which went into effect February 1, 2010, Millennium Laboratories' will assist Aetna participating physicians nationwide with state-of-the-art therapeutic drug monitoring services and tools.
The U.S. Food and Drug Administration (FDA) has approved raltegravir tablets for treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.
The U.N. World Food Programme (WFP) on Tuesday posted an infographic that answers such questions as "how many people does WFP feed each year?" and "how much does that cost and where does it get the money?"
UCLA AIDS Institute researchers successfully removed CCR5 - a cell receptor to which HIV-1 binds for infection but which the human body does not need - from human cells. Individuals who naturally lack the CCR5 receptor have been found to be essentially resistant to HIV.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Elizabeth Branson, 4681 Sierra Vista Ave Apt 307, Riverside, CA 92505-8561 Ph: (909) 800-3532 | Elizabeth Branson, 2010 E 1st St # 100, Santa Ana, CA 92705-4079 Ph: (909) 800-3532 |
News Archive
Those have undergone extensive back surgery and need repeated X-rays to monitor their progress may soon have access to a new technology that skips the X-rays and repeated radiation exposure, opting instead for an innovative, noninvasive, non-X-ray device that evaluates spinal movement.
Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, announced today a national agreement with Aetna, one of the nation's leading diversified health care benefits companies that serves approximately 36.3 million people. Under the terms of the three-year ancillary services agreement which went into effect February 1, 2010, Millennium Laboratories' will assist Aetna participating physicians nationwide with state-of-the-art therapeutic drug monitoring services and tools.
The U.S. Food and Drug Administration (FDA) has approved raltegravir tablets for treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.
The U.N. World Food Programme (WFP) on Tuesday posted an infographic that answers such questions as "how many people does WFP feed each year?" and "how much does that cost and where does it get the money?"
UCLA AIDS Institute researchers successfully removed CCR5 - a cell receptor to which HIV-1 binds for infection but which the human body does not need - from human cells. Individuals who naturally lack the CCR5 receptor have been found to be essentially resistant to HIV.
› Verified 7 days ago
Mr. Gerardo M De Jesus, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 550 N Flower St, Santa Ana, CA 92703 Phone: 714-647-4170 | |
Miss Sonia Sedano, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1400 N Main St, Santa Ana, CA 92701 Phone: 888-499-9303 | |
Melissa A Medellin, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1002 N Fairview St, Santa Ana, CA 92703 Phone: 714-835-8501 | |
Mr. Ramoncito Llorin Cimarra, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2001 E 4th St Ste 200, Santa Ana, CA 92705 Phone: 562-735-9541 | |
Kimberly A Umansky, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1751 E Garry Ave, Santa Ana, CA 92705 Phone: 877-896-7350 | |
Yingxuan Law, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1801 Park Court Pl Bldg H, Santa Ana, CA 92701 Phone: 206-817-2984 |